Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 0.1.

  • Voyager Therapeutics' Asset Utilization Ratio fell 7294.09% to 0.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1, marking a year-over-year decrease of 7294.09%. This contributed to the annual value of 0.21 for FY2024, which is 7804.73% down from last year.
  • As of Q3 2025, Voyager Therapeutics' Asset Utilization Ratio stood at 0.1, which was down 7294.09% from 0.13 recorded in Q2 2025.
  • Over the past 5 years, Voyager Therapeutics' Asset Utilization Ratio peaked at 0.77 during Q4 2023, and registered a low of 0.08 during Q3 2021.
  • For the 5-year period, Voyager Therapeutics' Asset Utilization Ratio averaged around 0.35, with its median value being 0.29 (2024).
  • As far as peak fluctuations go, Voyager Therapeutics' Asset Utilization Ratio plummeted by 8839.84% in 2021, and later skyrocketed by 40954.14% in 2023.
  • Quarter analysis of 5 years shows Voyager Therapeutics' Asset Utilization Ratio stood at 0.2 in 2021, then increased by 21.1% to 0.24 in 2022, then surged by 223.5% to 0.77 in 2023, then plummeted by 74.76% to 0.2 in 2024, then crashed by 47.38% to 0.1 in 2025.
  • Its Asset Utilization Ratio stands at 0.1 for Q3 2025, versus 0.13 for Q2 2025 and 0.18 for Q1 2025.